Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice
The RESPOND Study and RESPOND Extension Cohort
Nicolas M. Van Mieghem, Jochen Wöhrle, David Hildick-Smith, Sabine Bleiziffer, Daniel J. Blackman, Mohamed Abdel-Wahab, Ulrich Gerckens, Axel Linke, Hüseyin Ince, Peter Wenaweser, Dominic J. Allocco, Ian T. Meredith and Volkmar Falk
Improvements from baseline in mean aortic valve pressure gradient and mean aortic valve area were maintained at 1 year (p < 0.001 for both). Echocardiographic data were independently assessed by a core laboratory. Data are mean ± SD; p values are derived from a paired t-test analysis among patients with data available at both baseline and 1 year. RESPOND = Repositionable Lotus Valve System—Post-Market Evaluation of Real World Clinical Outcomes trial.